Share on StockTwits

Trupanion (NASDAQ:TRUP) announced its earnings results on Tuesday. The company reported ($2.25) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($4.30) by $2.05, Analyst Ratings News reports.

Several analysts have recently commented on the stock. Analysts at Cowen and Company initiated coverage on shares of Trupanion in a research note on Tuesday, August 12th. They set an “outperform” rating and a $12.00 price target on the stock. On the ratings front, analysts at Canaccord Genuity initiated coverage on shares of Trupanion in a research note on Tuesday, August 12th. They set a “buy” rating and a $13.00 price target on the stock. Finally, analysts at Barclays initiated coverage on shares of Trupanion in a research note on Tuesday, August 12th. They set an “overweight” rating and a $15.00 price target on the stock. Five research analysts have rated the stock with a buy rating, The company presently has a consensus rating of “Buy” and a consensus target price of $14.40.

Trupanion (NASDAQ:TRUP) traded down 0.57% during mid-day trading on Wednesday, hitting $8.65. The stock had a trading volume of 27,738 shares. Trupanion has a 52-week low of $8.50 and a 52-week high of $11.95. The stock has a 50-day moving average of $9.77 and a 200-day moving average of $9.77. The company’s market cap is $240.3 million.

Trupanion, Inc, is a direct-to-consumer monthly subscription service providing a medical insurance plan for cats and dogs throughout the United States, Canada and Puerto Rico.

Receive News & Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.